Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

(03) 9028 2888

clients@freshequities.com

ImpediMed Limited

INVESTOR PRESENTATION - ImpediMed Limited

ASX:IPD

ImpediMed Limited

Health

ImpediMed Limited (IPD) is a global company with offices in Australia and the USA engaged in the development of medical devices employing bioimpedance spectroscopy technologies with a focus on medical applications for use in a variety of healthcare segments especially for monitoring of tissue composition and fluid status. Currently, IPD operates in two segments which are medical and test & measurement segment.

Read more

Market Cap

$163.18m

Price at Close

$0.13

4w avg. Volume

2.01m

4w avg. Turnover

$256.15k

Announcements
announcementt+2 movementdate
  • Change in substantial holding

    Shareholder Details

  • 0.00%

    11 Jan 2021

0.00%

11 Jan 2021
  • Change in substantial holding

    Shareholder Details

  • 0.00%

    11 Jan 2021

0.00%

11 Jan 2021
  • PREVENT Trial Finishes, Final Patient Completes Follow-up

    Progress Report · Market sensitive

  • 0.00%

    11 Jan 2021

0.00%

11 Jan 2021
  • Ceasing to be a substantial holder from AEF

    Shareholder Details

  • 0.00%

    08 Jan 2021

0.00%

08 Jan 2021
  • Appendix 2A

    Issued Capital

  • +4.00%

    06 Jan 2021

+4.00%

06 Jan 2021
  • Option Exercise and Preliminary Quarterly Cash Flow Results

    Periodic Reports · Market sensitive

  • +4.00%

    06 Jan 2021

+4.00%

06 Jan 2021
  • Change of Director's Interest Notice - Donald Williams

    Shareholder Details

  • +4.00%

    06 Jan 2021

+4.00%

06 Jan 2021
  • Change of Director's Interest Notice - Amit Patel

    Shareholder Details

  • +4.00%

    06 Jan 2021

+4.00%

06 Jan 2021
  • Change of Director's Interest Notice - Scott Ward

    Shareholder Details

  • +4.00%

    06 Jan 2021

+4.00%

06 Jan 2021
  • Change of Director's Interest Notice - Dr Robert Graham

    Shareholder Details

  • +4.00%

    06 Jan 2021

+4.00%

06 Jan 2021
Market Data

Current Price

$0.13

52WK HIGH

$0.185

52WK LOW

$0.032

1YR RETURN

-23.53%

1YR RETURN VS. SECTOR

-62.03%

90 DAY RETURN

+60.49%

ASX RANK

682

/2,046

SECTOR RANK

61

/168

SHARES OUTSTANDING

1.26b
ASX:IPD

ImpediMed Limited

Health

ImpediMed Limited (IPD) is a global company with offices in Australia and the USA engaged in the development of medical devices employing bioimpedance spectroscopy technologies with a focus on medical applications for use in a variety of healthcare segments especially for monitoring of tissue composition and fluid status. Currently, IPD operates in two segments which are medical and test & measurement segment.

Read more

Market Cap

$163.18m

Price at Close

$0.13

4w avg. Volume

2.01m

4w avg. Turnover

$256.15k

ASX:IPD is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.